Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Other: Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test Sponsors: Fudan University; Shanghai Weihe Medical Laboratory Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma Interventions: Combination Product: mFOLFIRINOX plus radiotherapy Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
Conditions: Pancreatic Ductal Adenocarcinoma (PDAC); 16S rRNA Amplicon Sequencing; Untargeted Metabolome Analysis Interventions: Other: 16S rRNA amplicon sequencing and untargeted metabolomics Sponsors: Qilu Hospital of Shandong University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
Conditions: Advanced Solid Tumor; Metastatic Colorectal Carcinoma; Head and Neck Squamous Cell Carcinoma; Non-small Cell Lung Cancer; Pancreatic Ductal Adenocarcinoma Interventions: Drug: FPI-2053; Drug: [111In]-FPI-2107; Drug: [225Ac]-FPI-2068 Sponsors: Fusion Pharmaceuticals Inc.; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Conditions: Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Other: Fludeoxyglucose F-18; Other: Gallium Ga 68 Gozetotide; Drug: Lutetium Lu 177 Vipivotide Tetraxetan; Procedure: Positron Emission Tomography; Procedure: Single Photon Emission Computed Tomography; Drug: Vorinostat Sponsors: University of Washington; Novartis; Institute for Prostate Cancer Research (IPCR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Conditions: Prostate Cancer; Prostate Adenocarcinoma; Prostate Cancer Metastatic; Castration-resistant Prostate Cancer Sponsors: Duke University; University of Wisconsin, Madison; Memorial Sloan Kettering Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
CG Pharmaceuticals Announces the Commencement of Phase 2 Study for Metastatic Pancreatic Cancer
ORINDA, Calif., Nov. 17, 2023. CG Pharmaceuticals announces the commencement of Phase 2 study for metastatic pancreatic ductal adenocarcinoma (PDAC) with the recommended Phase 2 dose (RP2D) of ivaltinostat (ClinicalTrials.gov ID NCT05249101).
The... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 18, 2023 Category: Pharmaceuticals Source Type: clinical trials
ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study
Conditions: Colorectal Adenocarcinoma Interventions: Dietary Supplement: Impact Oral ® Sponsors: Istituto Oncologico Veneto IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
Conditions: Pancreas Cancer; Pancreatic Adenocarcinoma Interventions: Procedure: Systematic lymphadenectomy Sponsors: Universita di Verona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
Conditions: Locally Advanced Pancreatic Adenocarcinoma; Stage III Pancreatic Cancer American Joint Committee on Cancer v8; Unresectable Pancreatic Adenocarcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Distal Pancreatectomy; Procedure: Laparoscopy; Procedure: Magnetic Resonance Imaging; Procedure: Pancreaticoduodenectomy; Other: Questionnaire Administration; Procedure: Surgical Procedure; Procedure: Total Pancreatectomy Sponsors: University of Southern California; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Conditions: Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Stomach Neoplasms; Pancreatic Ductal Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma; Small Cell Lung Carcinoma Interventions: Drug: SGN-CEACAM5C Sponsors: Seagen Inc.; Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Study of RMC-6291 in Combination With RMC-6236 in Participants With Advanced KRAS G12C Mutant Solid Tumors
Conditions: Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Interventions: Drug: Assigned interventions Sponsors: Revolution Medicines, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Conditions: Adenocarcinoma; Carcinoma; Neoplasms Interventions: Other: collection of biological samples Sponsors: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
Conditions: Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Interventions: Drug: WX390; Drug: Toripalimab Sponsors: Shanghai Jiatan Pharmatech Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophagogastric Adenocarcinoma Interventions: Drug: Sacituzumab govitecan Sponsors: Institut f ür Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
